8th Edition of the Hybrid Symposium on Exercise Echocardiography – Hartcentrum Hasselt – Liferay DXP

We use exercise echocardiography in the evaluation of unexplained dyspnea in valvular or grown-up congenital heart disease and in athletes. Adding cardiopulmonary exercise testing may reveal alternative mechanisms of dyspnea, quantify exercise capacity, and determine prognosis. Date: Saturday, March 29, 2025 Location: Auditorium campus Virga Jesse; Stadsomvaart 11, 3500 Hasselt Register: Please register before March 15, 2025 via this link or the QR code. Participation is free Accreditation is requested

Read the full article here

Source: www.jessazh.be

Categories: Cardiologists, General Medicine News

Tweets with this article

Jan Verwerft

📢 Exciting News! Registration for the ExerciseEcho Symposium is OPEN! 🎉 Join the ExerciseEcho Symposium to explore how CPETecho revolutionizes evaluating exercise limitations and guiding care in HFpEF and valvular heart disease. 🔗 Register now: https://t.co/N4RJ10gTAY

Mechanical circulatory support for patients with infarct-related cardiogenic shock: a state-of-the-art review

Acute myocardial infarction-related cardiogenic shock (AMI-CS) is a severe, life-threatening condition characterised by inadequate tissue perfusion due to the heart’s inability to pump blood effectively.…

Diego Segura January 17, 2025

Donald Trump’s inauguration moved indoors in frigid Washington DC

The last president to be sworn-in indoors was Ronald Reagan in 1985, when cold weather also plagued the US Capitol.

Hany Ragy January 17, 2025

Support the Foundation

At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions…

AATS January 17, 2025

Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials

Statins, ezetimibe and statins-ezetimibe combination therapy are recommended lipid-lowering therapies (LLTs) in children with heterozygous familial hypercholesterolaemia (HeFH). However, their relative effectiveness is not well…

SABOURETCardiologist January 17, 2025

ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023 | Hypertension

ACE2 (angiotensin-converting enzyme 2) is a monocarboxypeptidase that cleaves Ang II (angiotensin II) among other substrates. ACE2 is present in the cell membrane of many…

Hypertension January 17, 2025

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

TCTMD January 17, 2025

Article Commentary: “Endovascular Thrombectomy Alone for Large Vessel Occlusion: A Cost-Effectiveness Evaluation Based on Meta-Analyses”

The management of acute ischemic stroke due to large vessel occlusion (LVO) has evolved significantly in recent years. While the combination of intravenous thrombolysis (IVT)…

Stroke AHA/ASA January 17, 2025

Related Articles